Sana Biotechnology, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Sana Biotechnology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2024.
  • Sana Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$50.3M, a 55.9% increase year-over-year.
  • Sana Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$245M, a 32.3% increase year-over-year.
  • Sana Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$283M, a 5.11% decline from 2022.
  • Sana Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$269M, a 24.3% increase from 2021.
  • Sana Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$356M, a 24.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$245M -$50.3M +$63.7M +55.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$309M -$107M -$25.4M -30.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-08
Q4 2023 -$283M -$88.1M -$7.67M -9.54% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$276M $984K +$86.1M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$362M -$114M -$41.5M -57.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$320M -$82.1M -$50.7M -161% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-08
Q4 2022 -$269M -$80.4M +$30.3M +27.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$300M -$85.1M -$1.86M -2.23% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$298M -$72.5M -$91.1M -488% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$207M -$31.4M +$149M +82.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$356M -$111M +$2.44M +2.16% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$358M -$83.3M -$31.8M -61.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$327M $18.7M +$106M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-02
Q1 2021 -$433M -$181M -$148M -449% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-02
Q4 2020 -$285M -$113M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-16
Q3 2020 -$51.5M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$87.8M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-08
Q1 2020 -$32.9M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.